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Ubiquitination and the reverse process deubiquitination regulate protein stability and function during
animal development. The Drosophila USP5 homolog Leon functions as other family members of uncon-
ventional deubiquitinases, disassembling free, substrate-unconjugated polyubiquitin chains to replenish
the pool of mono-ubiquitin, and maintaining cellular ubiquitin homeostasis. However, the signiﬁcance of
Leon/USP5 in animal development is still unexplored. In this study, we generated leon mutants to show
that Leon is essential for animal viability and tissue integrity during development. Both free and sub-
strate-conjugated polyubiquitin chains accumulate in leon mutants, suggesting that abnormal ubiquitin
homeostasis caused tissue disorder and lethality in leon mutants. Further analysis of protein expression
proﬁles in leon mutants shows that the levels of all proteasomal subunits were elevated. Also, proteaso-
mal enzymatic activities were elevated in leon mutants. However, proteasomal degradation of ubiquiti-
nated substrates was impaired. Thus, aberrant ubiquitin homeostasis in leon mutants disrupts normal
proteasomal degradation, which is compensated by elevating the levels of proteasomal subunits and
activities. Ultimately, the failure to fully compensate the dysfunctional proteasome in leonmutants leads
to animal lethality and tissue disorder.
 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Ubiquitination is an important cellular process to respond to
signal stimulation, leading to tissue patterning and differentiation
during animal development. Protein substrates are ubiquitinated
repeatedly by the series of E1 activating, E2 conjugating and E3
ligating enzymes to build up polyubiquitinated chains [1]. Poly-
ubiquitinated substrates are then recognized, deubiquitinated,
and degraded by the proteasome. Deubiquitinases (DUBs), the
large family of enzymes that deconjugate polyubiquitin chains
from protein substrates, are often considered as rivalry to ubiqui-
tination in many cellular functions [2,3].
DUBs cleave ubiquitin from mono- or poly-ubiquitin-conju-
gated protein substrates, linear ubiquitin precursors and unan-
chored polyubiquitin chains [4]. The universal enzymatic action
of DUBs is to hydrolyze the ester or amide bond at carboxyl-termi-
nus of ubiquitin [4]. However, the large DUB family of more than
one hundred members in the human genome, for example, canbe classiﬁed into ﬁve classes according to their protein sequences
[3–5]. In four of the ﬁve classes, the DUBs are cysteine proteases,
including ubiquitin speciﬁc proteases (USPs), ubiquitin C-terminal
hydrolases (UCHs), otubian proteases (OTUs) and Machado–Joseph
disease proteases (MJDs). The DUBs of the non-cysteine protease
contain JAB1/MPN domain-associated metalloisopeptidase (JAMM
domain) activity [3–5]. Mutations in many DUBs have been shown
to associate with cancers and neurodegenerative diseases [6,7].
There are 41 DUBs in the Drosophila genome with only a handful
of them being revealed for their developmental roles [8]. Nonstop
is required for photoreceptor axon growth regulated by glial cells
[9], Fat facets regulates the ubiquitination status of Liquid facets
in retina patterning [10], and DUBAI stabilizes DIAP1 to suppress
apoptosis [11]. However, the functions for most of Drosophila DUBs
are still unknown.
In contrast to other DUBs that deconjugate mono-ubiquitin or
polyubiquitin chains from protein substrates, human USP5 recog-
nizes and deconjugates free, unanchored polyubiquitin chains to
mono-ubiquitin, thus recycling ubiquitin for further usage [12].
This cleavage process requires conserved domains of USP5: the
N-terminal Zn2+-stabilized ZnF UBP domain that forms a pocket
to recognize the di-glycine motif in the C-terminal ubiquitin of
370 C.-H. Wang et al. / Biochemical and Biophysical Research Communications 452 (2014) 369–375the polyubiquitin chain, two UBA domains that bind ubiquitin of
the polyubiquitin chain, and conserved cysteine and histidine
boxes that constitute the catalytic site [13]. The homologues in
yeast and Arabidopsis thaliana also have the same structure and
cleavage capability [14–16]. The USP5 family of DUBs assumes a
key regulatory role for ubiquitin homeostasis in cells. In yeast, free
polyubiquitin chains serve as the ubiquitin reservoir that main-
tains ubiquitin at adequate levels in normal conditions and rapidly
provides ubiquitin for substrate conjugation under stress condi-
tions [17]. In addition to the disassembly of polyubiquitin chains,
USP5 is also important to the stability of protein substrates. Accu-
mulation of polyubiquitin chains in USP5 knockdown cells pro-
motes p53 accumulation [15].
Drosophila is an excellent model system to study gene functions
in developmental processes. We study the function of the USP5
homologue Leon ﬁrst by isolating three mutant alleles. In leon
mutants, brain lobes and imaginal disks are dramatically reduced.
Leon is expressed ubiquitously throughout developmental stages.
Consistent with human USP5, Leon is capable to cleave unanchored
lysine48-linked polyubiquitin chains. The animal lethality, abnor-
mal tissues and accumulation of polyubiquitin chains are com-
pletely restored to normality by ubiquitous expression of Leon.
However, expression of the enzyme-dead version of Leon fails to
rescue these defects. Furthermore, proteasomal degradation of
protein substrates is impaired in leon mutants. Surprisingly,
proteasomal enzymatic activities and proteasomal subunit levels
are elevated in leon mutants, suggesting a compensatory mecha-
nism when ubiquitin homeostasis is interfered. Thus, leon is an
essential gene for Drosophila development and required for ubiqui-
tin homeostasis to avoid dysfunction of proteasomal degradation.
2. Materials and methods
2.1. Fly stocks
leon1, leon2 and 19-2 alleles and GFP-leon-GR were described in
this study, and wild-type control w1118 was used to backcross all
mutant alleles for at least ﬁve generations. All ﬂies were reared
at 25 C.
UAS-3xFlag-leon and UAS-3xFlag-ED-leon were constructed by
fusing 3 Flag repeats (DYKDHDGDYKDHDIDYKDDDDK) at the
N-terminus of leon cDNA. UAS-CL1-GFP [18] has been described.
tubP-GAL4 and 24B-GAL4 were obtained from Bloomington
Drosophila Stock Center.
2.2. Immunostaining
Larvae were dissected and ﬁxed as previously described [19].
Primary antibodies: chicken anti-GFP (1:100, Abcam), goat anti-
HRP conjugated FITC or TRITC (1:200 Jackson ImmunoResearch),
mouse anti-Leon (1:100) generated against GST-Leon fusion pro-
tein (LTK BioLaboratories) and TRITC conjugated phalloidin
(1:2000; Sigma Co.) Tissues were mounted in PBS containing
87.5% glycerol and 0.22 M 1,4-diaza-byciclo (2.2.2) octane (Dabco,
Sigma Co.). Images were acquired by confocal Z-stack scanning
(Zeiss LSM510) using 20 objectives and processed by LSM 5
image examiner and Adobe Photoshop.
2.3. Western blot and deubiquitination assay
Third instar larvae or transfected S2 cells were homogenized in
lysis buffer (150 mM NaCl, 5 mM EDTA, 50 mM K2HPO4, 1% triton-
X-100 and 20 mM Tris–HCl, pH 7.4) supplemented with protease
inhibitor cocktails (Roche) and 1 mM PMSF. For deubiquitination
assay, puriﬁed GST-Leon and GST-ED-Leon were incubated with
K48-linked or K63-liked polyubiquitin (1 lg, Enzo Co.) in a reactionmixture (10 ml containing 20 mM Tris–HCl, pH 7.5, and 0.5 mM
DTT) for 1 h at 30 C. For Western blot, antibodies against proteaso-
mal subunits 20S-a, P39A, P42A, and P54 (1:100; Santa Cruz Bio-
technology), ubiquitin (P4D1, 1:1000; Santa Cruz Biotechnology),
a-Tubulin (1:10,000; Sigma Co.) and Leon (1:1000) were used.
2.4. In vitro enzymatic activity assay
20 lM of each ﬂuorogenic substrates Z-LLE-AMC, Boc-LRR-AMC
and Suc-LLVY-AMC [20] (Enzo Co.) were incubated with 20 lg
larva lysates of w1118, leon1/19-2 and leon2/19-2 in buffer A (Glyc-
erol 10%, 25 mM Tris–HCl, pH 7.4, 10 mM MgCl2, 1 mM ATP and
1 mM DTT) for 1 h at 25 C. The reactivities were measured with
excitation at 380 nm and emission at 460 nm (Enspire Multilabel
Plate Reader, Perkin Elmer).
2.5. SILAC method for ﬂies
Wild type larvae were reared in normal ﬂy food and leon1/19-2
larvae were reared in food with heavy amino acid (Lys-6). Larvae
were homogenized in lysis buffer (150 mM NaCl, 5 mM EDTA,
50 mM K2HPO4, 1% triton-X-100 and 20 mM Tris–HCl, pH 7.4) sup-
plemented with protease inhibitor cocktails (Roche) and 1 mM
PMSF. Each 0.5 lg of wild type and leon1/19-2 larval lysates were
mixed and preformed in 10% SDS–PAGE. Gel with proteins were
further digested by trypsin and examined by Mass-Spec machine
(LTQ-Orbitrap XL, Thermo Fisher Scientiﬁc). The indicated protein
had been detected with heavy (H) and light (L) peptides. H/L ratio
provided the relative amount of indicted protein between different
protein sources [21].
3. Results
3.1. Isolation of leon mutants
To address the developmental role of the Drosophila USP5
homolog, we isolated mutant alleles by P-element-mediated exci-
sion of P[EPgy2]BtbVIIEY07802, inserted in the ﬁrst intron of BtbVII
next to leon (CG12082, Fig. 1A). About 100 excision alleles were
examined by PCR. Shorter PCR products indicate imprecise excision
events, and were sequenced to uncover the deleted region. The
19-2 allele was truncated for a 1 kb region including the shared
promoter region, and the predicted ATG codon of leon (Fig. 1A
and B). Homozygotes for the 19-2 allele were lethal, which could
be due to loss of leon, BtbVII or both. To examine the cause of the
lethality of 19-2, the genomic rescue transgene GFP-leon-GR was
constructed by fusing GFP to leon cDNA driven by the genomic
sequence between the translational start sites of BtbVII and leon.
The GFP-leon-GR (Fig. 1A) was introduced into 19-2 homozygotes
and the resultant ﬂies survived to adulthood with normal appear-
ance (Fig 1D). Thus, the lethality of 19-2 is due to the lack of leon
gene activity.
To identify speciﬁc leon alleles, 4500 EMS-mutagenized alleles
were tested for failure to complement the lethality of 19-2. The
alleles failed to complement 19-2 were further sequenced in the
leon and BtbVII coding regions. Two lethal alleles carrying single
amino acid substitutions in the ZnF UBP domain of Leon were iso-
lated in the screen. The leon1 allele carries a substitution at Cys224
by Tyr, and the leon2 Gly225 by Arg (Fig. 1C). No amino acid substi-
tutions in BtbVII were identiﬁed in leon1 and leon2. We then exam-
ined the lethal phase of mutants with combinations of different
leon alleles. Animals homozygous or transheterozygous for 19-2
and leon1 died at the late third-instar larval stage, whereas those
homozygous for leon2 and transheterozygous carrying one leon2
allele survived to early pupal stages. These results indicate that
19-2 and leon1 are either null or close-to-null allele while leon2 is
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Fig. 1. Characterization of leon mutants. (A) Diagram shows CG12082/leon locus next to BtbVII, P[EPgy2]BtbVIIEY07802 insertion, 19-2 deletion and the GFP-leon-GR construct
which is the fusion of promoter (P), leon and GFP (G) as shown. (B) PCR detection of deleted regions in excision alleles. The pair of primers, as represented by red arrows in (A)
was used to amplify 2.6 kb genomic sequence. The downshifted band of PCR product shown in 19-2 (lane 9) was sequenced to conﬁrm the deletion. (C) Diagram shows Leon
protein (827 a.a.) structure, including one zinc-ﬁnger ubiquitin binding domain (Z) in which mutations in leon1 and leon2 alleles were indicated, two ubiquitin-associated
domains, U1 and U2, and one peptidase C19 domain that is split into a cysteine (C) and a histidine box (H). (D) Chart shows complementary results of leon mutants by lethal
stages. The allelic strength is 19-2 = leon1 > loen2. Introducing of GFP-leon-GR in leonmutants rescued the lethality of all allelic combinations to adult stage. (For interpretation
of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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leon-GR transgene also rescued leon1 and leon2 mutants to adult-
hood, conﬁrming that leon is essential for developmental
processes.
3.2. Abnormality in brain lobes and imaginal disks in leon mutants
To study Leon expression, the mouse anti-Leon antibodies were
generated against puriﬁed GST-Leon fusion protein. The Leon anti-
bodies recognized a protein of slightly larger than 100 kDa,
although the expected Leon size is about 91 kDa (Fig. 2A). The sig-
nal was completely absent in 19-2, suggesting that 19-2 is a protein
null allele of leon. The Leon expressions were normal in the protein
size and levels in leon1 and leon2 homozygotes and the levels were
reduced in leon1/19-2 and leon2/19-2 transheterozygotes. Immuno-
staining of larval tissues by Leon antibodies showed a ubiquitous
expression pattern of Leon in all tissues. Leon expression was com-
pletely absent in 19-2 homozygous larvae (Fig. 2B).
The ubiquitous expression pattern of Leon suggests that Leon
might function in several tissues. Consistently, null or close-to-null
leon mutants survived to the late third-instar larval stage. While
leon larvae appeared normal in body size, brain lobes and wing
disks became smaller in leon1/19-2 mutants (Fig. 2C). The hypo-
morphic leon2/19-2 larvae that survived to early pupal stages dis-
played no such phenotypes. While there were differential tissue
growth rates in hypomorphic and null mutants, both of them were
slow in larval growth as compared to heterozygous siblings.
We then tested whether these defects were caused by the lack
of leon and whether the leon enzymatic activity is involved. The
ubiquitous expression of wild type Leon (UAS-leon) by tubP-GAL4
rescued leon1/19-2 lethality and restored tissue development
(Fig. 2C). We also generated the enzyme-dead Leon (UAS-ED-leon)
with Cys341 substituted by Ala in the catalytic site. Ubiquitous
expression of ED-Leon, however, failed to rescue animal lethality
and tissue growth in leon1/19-2. These results indicate that the
deubiquitinating activity of Leon is essential for its role in
development.
3.3. Leon is a deubiquitinase
Protein sequence alignment suggests that Leon is homologous
to human USP5, A. thaliana UBP14 and yeast UBP14, which processpolyubiquitin chains to mono-ubiquitin [14–16]. We tested
whether Leon also functions in the same process. Puriﬁed GST-
Leon effectively deconjugated Lys48-linked polyubiquitin chains
to mono-ubiquitin, while GST had no such effect (Fig. 3A, left
panel). When incubated with Lys63-linked polyubiquitin chains,
the deubiquitinating activity of GST-Leon was less effective
(Fig. 3A, right panel). We also puriﬁed the enzyme-dead ED-Leon,
which failed to deconjugate both Lys48- and Lys63-linked poly-
ubiquitin chains (Fig. 3A).
We next examined whether the ubiquitin levels are altered in
leon mutants. In all leon mutants we examined, free polyubiquitin
chains were increased, exhibiting a ladder pattern corresponding
to Lys48-linked polyubiquitin chains (Fig. 3B). Whereas moderate
increases were detected in hypomorphic leon2 and leon2/19-2
mutants, large increases were found in null or close-to-null
mutants, leon1, 19-2, and leon1/19-2. Interestingly, mono-ubiquitin
levels were also increased in all mutants, which were more in
hypomorphic mutants. In addition, smeared signals at high molec-
ular weights representing substrate-conjugated polyubiquitin
chains were also detected in null and close-to-null mutants. The
levels of free polyubiquitin chains, mono-ubiquitin and sub-
strate-conjugated polyubiquitin chains were differentially elevated
in leon mutants, suggesting the complex regulation of ubiquitin
homeostasis by Leon.
We then tested whether the enzymatic activity of Leon is
required to suppress the levels of polyubiquitin chains in vivo.
Ubiquitous expression of wild-type UAS-leon by the ubiquitous dri-
ver tubP-GAL4 suppressed the formation of free and conjugated
polyubiquitin chains (Fig. 3C, lane 3). However, ubiquitous expres-
sion of UAS-ED-leon failed to suppress polyubiquitin chain forma-
tion (Fig. 3C, lane 4). These results suggest that the
accumulations of polyubiquitin chains were caused by the lack of
Leon deubiquitinating activity.
3.4. Proteasomal degradation of substrates is interfered in leon
mutants
Accumulation of polyubiquitin chains in leon mutants might
block proteasomal degradation of ubiquitinated substrates, leading
to their accumulations [14]. This interpretation could explain the
accumulation of polyubiquitinated proteins in leon mutants on
western blot analysis (Fig. 3B and C). To test whether proteasomal
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the proteasomal substrate CL1-GFP [18]. When expressed by 24B-
GAL4 in muscles, CL1-GFP was almost undetectable (Fig. 4A). In
hypomorphic leon1/19-2, the levels of CL1-GFP were also almostundetectable. Strikingly, CL1-GFP accumulated at high levels in
close-to-null leon1/19-2 mutants (Fig. 4A). Quantiﬁcation of GFP
intensities at muscles showed signiﬁcant increases of CL1-GFP sig-
nals in leon1/19-2 mutants (Fig. 4B). These results, taken together
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C.-H. Wang et al. / Biochemical and Biophysical Research Communications 452 (2014) 369–375 373with western blot analysis (Fig. 3B and C), suggest that Leon is
required for normal proteasomal degradation of polyubiquitinated
substrates.
With the blockade of proteasomal degradation, we examined if
the enzymatic activities of the proteasome were compromised.
Fluorogenic substrates, Z-LLE-AMC, Boc-LRR-AMC and Suc-
LLVY-AMC, were used to detect the caspase-like, trypsin-like and
chymotrypsin-like activities of the proteasome, respectively [20].
Surprisingly, the enzymatic activities of leon mutants when
compared to wild-type control were either normal in hypomorphic
leon2/19-2 or higher in close-to-null leon1/19-2.While the proteaso-
mal degradation of protein substrates were hindered, the results
suggest that the accumulation of polyubiquitinated proteins in leon
mutants is not caused by inactivation of enzymatic activities of the
proteasome (Fig. 4C).
We have preformed a stable isotope labeling by amino acids in
cell culture (SILAC) method for Drosophila [21], to compare proteo-
mic expression proﬁles between wild-type and leon1/19-2 mutant
larvae. Among the differentially expressed proteins, we focused
on the levels of proteasomal subunits in this analysis and found
that all proteasomal subunits, including lid and core subunits, were
detected in this analysis, consistent with the idea that all proteos-
omal subunits are abundant in cells [22]. Surprisingly, all proteaso-
mal subunits were increased in protein levels to almost two folds
in the leon1/19-2 mutant (Table 1). To conﬁrm the increase in the
levels of proteasomal subunits, a collection of antibodies thatrecognize Rpn7 (P42A), Rpn9 (P39A) and Rpn10 (P54) of the 19S
complexes and a subunit of the proteasomal core complexes were
used in western blot analysis. Those four proteasomal subunits
were all increased in leon1/19-2 mutants. In leon2/19-2, Rpn7,
Rpn9 and a subunits were slightly increased and Rpn10 was
slightly decreased (Fig. 4D). Combined with the ﬂuorogenic sub-
strate assay for enzymatic activities, higher proteasomal activity
in leon1/19-2 mutants is likely attributed to higher levels of the
proteasome (Fig. 4C). The elevation of the proteasomal levels is
likely to compensate for the interfered proteasome, whose capacity
to degrade substrates is completely blocked in leon1/19-2 mutants.
4. Discussion
The molecular action of USP5 family members was clearly
depicted in many species [14–16]. However, the role of USP5 in
animal development is not clear. Our study in leon mutants for
the Drosophila USP5 has revealed roles in animal development.
Being an essential gene, null or close-to-null and hypomorphic leon
mutants were lethal at larval and pupal stages, respectively, sug-
gesting that Leon is required at least in two distinct developmental
stages. Interestingly, null or close-to-null but not hypomorphic
leon mutants displayed severe developmental disorder in larval
stages. Similar to USP5, Leon also has the ability to convert free
polyubiquitin chains into mono-ubiquitin. Consistent with allelic
strength in different combinations of mutant alleles, the amounts
Table 1
Chart shows elevation of proteasomal subunits in leon1/19-2 by SILAC method.
20S 19S lid 19S base
CG number Protein name Ratio (H/L) CG number Protein name Ratio (H/L) CG number Protein name Ratio (H/L)
CG18495 a-1 3.2 CG42641 Rpn3 1.6 CG7762 Rpn1 1.99
CG5266 a-2 1.95 CG1100 Rpn5 1.6 CG11888 Rpn2 1.94
CG9327 a-3 3.11 CG5289 Rpn6 2.45 CG7619 Rpn10 2.27
CG3422 a-4 2.5 CG5378 Rpn7 1.69 CG1341 Rpt1 2.24
CG10938 a-5 2.54 CG3416 Rpn8 2.62 CG5289 Rpt2 2.45
CG4904 a-6 2.3 CG10230 Rpn9 2.32 CG16916 Rpt3 1.95
CG1519 a-7 2.53 CG18174 Rpn11 2.24 CG3455 Rpt4 2.17
CG8392 b-1 2.91 CG4157 Rpn12 2.05 CG10370 Rpt5 2.15
CG3329 b-2 2.48 CG1489 Rpt6 2.19
CG11981 b-3 2.48
CG17331 b-4 3.5
CG12323 b-5 1.67
CG4097 b-6 2.73
CG12000 b-7 2.83
374 C.-H. Wang et al. / Biochemical and Biophysical Research Communications 452 (2014) 369–375of free polyubiquitin chains correlate with the animal lethal phases
and tissue disorders. Meanwhile, loss of Drosophila USP5 has been
shown to cause severe apoptosis in eye disks [23]. It is possible that
small brain lobes and wing disks in close-to-null leon1/19-2 were
due to severe apoptosis. Ultimately, severe disruption of ubiquitin
homeostasis in close-to-null leon1/19-2might induce apoptosis and
ﬁnally lethality. Hypomorphic leon mutants might tolerate mild
disruption of ubiquitin homeostasis and delay apoptosis until
pupal stages. This result also suggests that the stage of Drosophila
metamorphosis is vulnerable to deﬁcient ubiquitin homeostasis.
Accumulation of free polyubiquitin chains severely disrupts
ubiquitin homeostasis, leading to the inhibition of proteasomal
degradation of protein substrates. Accumulations of ubiquitinated
protein substrates are evident in western blots, showing smear sig-
nals at high molecular weights in null or close-to-null leonmutants
(Fig. 3B). By examining the proteasomal function reporter CL1-GFP,
we also showed the inhibition of proteasomal function in leon
mutants (Fig. 4A and B). Taken together, Leon/USP5 is important
to maintain ubiquitin homeostasis, and the unbalanced ubiquitin
levels in vivo have an impact on protein degradation by the protea-
some. We also found that the proteosomal level and enzymatic
activities were elevated when the proteasomal degradation was
hampered. Thus, when the ubiquitin homeostasis is unbalanced
and the proteasomal degradation is interfered, the proteasomal
levels are elevated, likely to compensate for the initial deﬁciency
in degrading polyubiquitinated proteins. The compensation mech-
anism eventually is not adequate to remove the accumulated pro-
teins, leading to cellular toxicity.
Mutations in DUBs are associated with diseases including can-
cers and neurodegeneration [6,7]. For example, USP7 destabilizes
tumor suppressor p53 through stabilizing Mdm2, the E3 ubiquitin
ligase for p53 [24]. Also, loss of USP5 in mammalian cells also
causes p53 stabilization by accumulation of free polyubiquitin
chains [15]. Thus, different DUBs may target the same substrate,
providing a multi-facet regulation or a cell-context dependent reg-
ulation. Until now, USP5 has been shown to link two carcinomas:
alterations of USP5 isoforms in glioblastoma tumorigenesis and
USP5 linked-suppression of p53 in melanoma [25,26]. Treatment
of DUBs inhibitor EOAI3402143, targeting to USP9X and USP5, suc-
ceed to suppress melanoma growth [26]. Thus, DUBs could be the
important targets for disease therapy [27].
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